Effect of preoperative Staphylococcus aureus screening / decolonization on surgical site infection following major othopaedic operations: a prospective study
AbstractBackground: Carriers of Staphylococcus aureus (S. aureus) have a higher likelihood of having surgical site infection (SSI). Aim: evaluate the impact of preoperative S. aureus screening and decolonization on the rate of SSI after major orthopaedic surgical operations. Methods: A prospective observational study was conducted on 400 patients scheduled for major orthopaedic surgical procedures at our institution between December 2013 to December 2014. The enrolled patients were divided into: intervention group (250 patients) who underwent the screening / decolonization protocol, and a control group (150 patients) with no implementation of the protocol. All patients were followed up for 3 months for postoperative S. aureus SSI. Findings: Of the 250 patients screened, 70 (28%) had positive nasal swabs for S. aureus. Among screened patients, 58 (23.2%) were identified as MSSA carriers, and 12 (4.8%) were identified as MRSA carriers. On post operative follow up, there were a total of 5 S. aureus SSI in the control group (3.3%, 95% CI 1.1-7.6%) and 3 in the intervention group (1.2%, 95% CI 0.25- 3.5% ). There was 2 MRSA infection in the control group (1.3%, 95% CI 0.2-4.7%), one MRSA infection in the intervention group (0.4%, 95% CI 0.01-2.2). Screening and decolonization lowered, the S. aureus SSI rate to 1.2% in screened/decolonized (intervention) versus 3.3% in those unscreened (control) patients. Conclusion: preoperative screening / decolonization of MRSA and MSSA carriers among patients undergoing major orthopaedic surgical operations using a combination of mupirocin and chlorhexidine is a safe protocol for reducing S. aureus SSI.
Copyright conditions: Copyright on any research article in the International Journal of Infection Control (IJIC) is retained by the author(s). Authors grant IJIC permission to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. IJIC conforms to the Creative Commons Attribution License (http://creativecommons.org) as terms and conditions of publishing research articles. In summary, anyone is free: • to copy, distribute, and display the work; • to make derivative works; • to make commercial use of the work; as long as: • the original author must be given credit; • for any reuse or distribution, it must be made clear to others what the license terms of this work are; • any of these conditions can be waived if the authors gives permission. Statutory fair use and other rights are in no way affected by the above. Authors' certification: In submitting a manuscript to IJIC, authors are requested to certify that: • They are authorized by their co-authors to enter into these arrangements. • They warrant, on behalf of themselves and their co-authors, that: o the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights; o they are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to IJIC are not in breach of any other obligation. If the law requires that the article be published in the public domain, they will notify IJIC at the time of submission; o the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy; o they have taken due care to ensure the integrity of the article.